Genrui offers the world's first chemiluminescence-based assay for seven lung cancer-associated autoantibodies, complementing CT imaging with immunological insights to support early-stage lung cancer screening and lung nodule risk stratification.
Products
Jul, 13, 2026
Feb, 17, 2026
Jul.13, 2026
Feb.17, 2026
Nov.25, 2025
Get in Touch
+86 755 26835560/1/2; +86 755 26678255
